Vycor Medical Inc (VYCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,589 | 1,461 | 1,223 | 1,393 | 1,142 |
| Cost of Goods | 167 | 145 | 141 | 135 | 133 |
| Gross Profit | 1,423 | 1,316 | 1,082 | 1,258 | 1,010 |
| Operating Expenses | 1,599 | 1,420 | 1,530 | 1,829 | 1,869 |
| Operating Income | -9 | 40 | -307 | -436 | -727 |
| Interest Expense | 104 | 103 | 92 | 88 | 78 |
| Other Income | 6 | 0 | -1 | 116 | 5 |
| Pre-tax Income | -107 | -63 | -400 | -408 | -800 |
| Net Income Continuous | -107 | -63 | -400 | -408 | -800 |
| Net Income Discontinuous | 0 | -7 | -5 | -27 | -22 |
| Net Income | $-107 | $-70 | $-405 | $-436 | $-823 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.01 | 0.00 | N/A | N/A | N/A |
| EBITDA(a) | $55 | $101 | $-245 | $-368 | $-670 |